4.3 Review

Epigenetics of Progression of Chronic Kidney Disease: Fact or Fantasy?

期刊

SEMINARS IN NEPHROLOGY
卷 33, 期 4, 页码 363-374

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semnephrol.2013.05.008

关键词

DNA methylation; microRNAs; chronic kidney disease (CKD); EMT; renal fibrosis

资金

  1. National Institutes of Health [R01 DK073665-01A1]
  2. National Heart, Lung and Blood Institute grants [268200900040C, 1R01 HL107241-02]
  3. National Institute for Diabetes and Digestive and Kidney Diseases National Institutes of Health grant [K01DK082646]

向作者/读者索取更多资源

Epigenetic modifications are important in the normal functioning of the cell, from regulating dynamic expression of essential genes and associated proteins to repressing those that are unneeded. Epigenetic changes are essential for development and functioning of the kidney, and aberrant methylation, histone modifications, and expression of microRNA could lead to chronic kidney disease (CKD). Here, epigenetic modifications modulate transforming growth factor p signaling, inflammation, profibrotic genes, and the epithelial-to-mesenchymal transition, promoting renal fibrosis and progression of CKD. Identification of these epigenetic changes is important because they are potentially reversible and may serve as therapeutic targets in the future to prevent subsequent renal fibrosis and CKD. In this review we discuss the different types of epigenetic control, methods to study epigenetic modifications, and how epigenetics promotes progression of CKD. (C) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据